All atropine therapy Articles
-
244Latest Myopia NewsFDA Review for Sydnexis’ SYD-101 Scheduled for Oct. 30
September 24, 2026 DEL MAR, Calif. — Sydnexis, Inc., announced that the U.S. Food and Drug Administration (FDA) has scheduled an Advisory...
-
1.5KLatest Myopia NewsSydnexis Partner Santen Wins U.K. Approval for Ryjunea to Slow Childhood Myopia
November 6, 2025 DEL MAR, Calif. — Sydnexis‘ partner Santen has announced that the U.K. Medicines and Healthcare products Regulatory Agency (MHRA)...
-
887Latest Myopia NewsFDA Delays Approval of Sydnexis’ SYD-101 for Myopia, Asking for More Evidence
October 24, 2025 DEL MAR, Calif. — The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to...
-
720Getting Started with Myopia ManagementSetting Your Fees
Since myopia management services and materials are not covered by insurance or vision benefit plans, adding the service is an opportunity for...
-
1.7KEditor’s PerspectiveAre You Practicing the Standard of Care?
October 1, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Standard of care refers to the level of care, skill, and...